

LOGICHECK Drug Test Urine Screening Cup (8 Drug Classes inc Alcohol) + Adulterants - Each
Tax included. Shipping calculated at checkout
LOGICHECK Drug Testing Urine Screening Cup is a rapid immunoassay device designed for the qualitative detection of multiple common drugs, drug metabolites, and alcohol in human urine. The cup features integrated adulterant testing and a secure screw-cap lid to support sample integrity during collection and handling. It is suitable for use in workplace screening, clinical environments, pathology, and other settings requiring quick and reliable urine drug and alcohol screening.
Features:
• Screens for 7 key drug classes
• Includes alcohol screening for detection of recent alcohol consumption
• Incorporates 6 adulterants and temperature check for validity
• Secure screw-cap lid design to reduce leakage and support sample integrity
• Cut-off levels comply with AS/NZS 4308:2023 Standards in Australia for screening
7 Key Drug Classes and Cut-off Levels
• Amphetamine (AMP) (300 ng/mL)
• Benzodiazepines (BZO) (200 ng/mL)
• Cocaine (COC) (300 ng/mL)
• Marijuana (THC) (50 ng/mL)
• Methamphetamine (MET) (300 ng/mL)
• Morphine/Opiate (MOP/OPI) (300 ng/mL)
Indications
• Screening for drug and alcohol use in workplace testing programs
• Clinical settings requiring rapid assessment of substance exposure
• Occupational health and rehabilitation use
• Pre-employment medicals or random testing
Features:
• Screens for 7 key drug classes
• Includes alcohol screening for detection of recent alcohol consumption
• Incorporates 6 adulterants and temperature check for validity
• Secure screw-cap lid design to reduce leakage and support sample integrity
• Cut-off levels comply with AS/NZS 4308:2023 Standards in Australia for screening
7 Key Drug Classes and Cut-off Levels
• Amphetamine (AMP) (300 ng/mL)
• Benzodiazepines (BZO) (200 ng/mL)
• Cocaine (COC) (300 ng/mL)
• Marijuana (THC) (50 ng/mL)
• Methamphetamine (MET) (300 ng/mL)
• Morphine/Opiate (MOP/OPI) (300 ng/mL)
Indications
• Screening for drug and alcohol use in workplace testing programs
• Clinical settings requiring rapid assessment of substance exposure
• Occupational health and rehabilitation use
• Pre-employment medicals or random testing

